Electromed (NYSE:ELMD) Shares Down 1.1%

Electromed, Inc. (NYSE:ELMD)’s share price dropped 1.1% on Tuesday . The company traded as low as $14.00 and last traded at $14.00. 36,003 shares changed hands during mid-day trading, an increase of 20% from the average daily volume of 30,013 shares. The stock had previously closed at $14.15.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised Electromed from a “buy” rating to a “strong-buy” rating in a report on Monday, May 13th.

Electromed Stock Performance

The company has a market capitalization of $121.24 million, a PE ratio of 28.00 and a beta of 0.25. The stock’s fifty day simple moving average is $15.72 and its 200-day simple moving average is $14.09.

Electromed (NYSE:ELMD) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.17 earnings per share for the quarter. The company had revenue of $13.87 million for the quarter. Electromed had a net margin of 8.14% and a return on equity of 10.97%.

Institutional Investors Weigh In On Electromed

Several institutional investors and hedge funds have recently modified their holdings of ELMD. Vanguard Group Inc. boosted its position in Electromed by 1.6% in the 1st quarter. Vanguard Group Inc. now owns 367,114 shares of the company’s stock valued at $5,929,000 after buying an additional 5,886 shares during the last quarter. Gamco Investors INC. ET AL lifted its stake in shares of Electromed by 32.6% in the first quarter. Gamco Investors INC. ET AL now owns 111,356 shares of the company’s stock worth $1,798,000 after acquiring an additional 27,356 shares in the last quarter. Hunter Associates Investment Management LLC lifted its stake in shares of Electromed by 7.1% in the first quarter. Hunter Associates Investment Management LLC now owns 86,200 shares of the company’s stock worth $1,391,000 after acquiring an additional 5,700 shares in the last quarter. Gabelli Funds LLC boosted its holdings in Electromed by 76.1% in the first quarter. Gabelli Funds LLC now owns 35,867 shares of the company’s stock valued at $579,000 after purchasing an additional 15,500 shares during the last quarter. Finally, Aristides Capital LLC grew its stake in Electromed by 22.1% during the 1st quarter. Aristides Capital LLC now owns 24,917 shares of the company’s stock valued at $402,000 after purchasing an additional 4,517 shares in the last quarter. Hedge funds and other institutional investors own 40.82% of the company’s stock.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.